Physician profile
Sohrab Fallahi
NPI 1497739270
$24,815.08
in general payments reported to CMS, 2019-2025
34 companies · $2,141 in 2025
The $2,141 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,698 · 2020: $2,490 · 2021: $3,341 · 2022: $1,935 · 2023: $2,175 · 2024: $3,035 · 2025: $2,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,351.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $11,774.26 | 2019-2025 | Enbrel, Otezla, Tavneos |
| Abbvie INC. | $3,298.61 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,365.85 | 2019-2025 | |
| Janssen Biotech, INC. | $1,242.26 | 2019-2025 | Tremfya, Simponi Aria |
| Pfizer INC. | $1,006.28 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $875.56 | 2020-2025 | Acthar |
| Glaxosmithkline, LLC. | $864.63 | 2019-2025 | Benlysta |
| Ucb, INC. | $735.36 | 2019-2025 | Cimzia, Bimzelx |
| Astrazeneca Pharmaceuticals LP | $555.14 | 2021-2025 | Saphnelo |
| Radius Health, INC. | $486.71 | 2019-2025 | Tymlos |
| E.R. Squibb & Sons, L.L.C. | $449.39 | 2019-2021 | |
| Aurinia Pharma U.S., INC. | $373.92 | 2021-2025 | Lupkynis |
| Genentech USA, INC. | $355.15 | 2019-2025 | Actemra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $295.17 | 2019-2025 | Cyltezo, Ofev |
| Ani Pharmaceuticals, INC. | $172.51 | 2022-2025 | Purified Cortrophin Gel |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $131.95 | 2023-2025 | Idacio |
| Alexion Pharmaceuticals, INC. | $114.39 | 2021-2024 | Strensiq |
| Octapharma USA, INC. | $109.92 | 2022-2024 | Octagam Immune Globulin (Human) |
| Organon LLC | $74.81 | 2023-2025 | Hadlima |
| Genzyme Corporation | $72.77 | 2023-2024 | |
| Mallinckrodt Enterprises LLC | $65.70 | 2019 | |
| Celgene Corporation | $62.28 | 2019 | |
| Depuy Synthes Sales INC. | $53.80 | 2021-2023 | Monovisc |
| Kiniksa Pharmaceuticals International, Plc | $47.90 | 2024 | Arcalyst |
| Hikma Pharmaceuticals USA | $47.63 | 2019 | |
| Janssen Scientific Affairs, LLC | $43.81 | 2021 | |
| Bioventus LLC | $24.66 | 2019 | |
| Mylan Institutional INC. | $23.86 | 2023 | Hulio |
| Sobi, INC | $19.16 | 2025 | |
| Scilex Pharmaceuticals INC. | $17.80 | 2024 | |
| Phathom Pharmaceuticals, INC. | $15.92 | 2024 | Voquezna |
| Ultragenyx Pharmaceutical INC. | $14.68 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $12.63 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sohrab Fallahi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.